Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
0 investors
7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
0 investors
0 investors
0 investors
0 investors
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
0 investors
0 investors
0 investors
0 investors
0 investors
Aatru Medical is a medical device company that develops wound care products, including NPSIMS, a negative pressure wound therapy (NPWT) system for surgical incision management aimed at reducing surgical site complications. Its products serve clinicians and patients, and the company is the parent of Exothermix, which supplies the oxygen scavenger used in NPSIMS.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
0 investors
0 investors
0 investors
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
0 investors
0 investors
0 investors
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
0 investors
0 investors